Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
31.35%
operating margin TTM
34.06%
revenue TTM
9.83 Billion
revenue per share TTM
38.3$
valuation ratios | |
|---|---|
| pe ratio | 31.73 |
| peg ratio | 23.61 |
| price to book ratio | 4.69 |
| price to sales ratio | 9.99 |
| enterprise value multiple | 26.09 |
| price fair value | 4.69 |
profitability ratios | |
|---|---|
| gross profit margin | 86.28% |
| operating profit margin | 34.06% |
| pretax profit margin | 37.95% |
| net profit margin | 31.35% |
| return on assets | 14.78% |
| return on equity | 19.62% |
| return on capital employed | 19.59% |
liquidity ratios | |
|---|---|
| current ratio | 2.36 |
| quick ratio | 2.00 |
| cash ratio | 1.10 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 369.11 |
| operating cycle | 429.71 |
| days of payables outstanding | 915.23 |
| cash conversion cycle | -485.53 |
| receivables turnover | 6.02 |
| payables turnover | 0.40 |
| inventory turnover | 0.99 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.07 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.07 |
| total debt to capitalization | 0.07 |
| interest coverage | 311.98 |
| cash flow to debt ratio | 2.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | 13.06 |
| cash per share | 24.60 |
| operating cash flow per share | 14.55 |
| free cash flow operating cash flow ratio | 0.90 |
| cash flow coverage ratios | 2.03 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 9.76 |
Frequently Asked Questions
When was the last time Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported earnings?
Vertex Pharmaceuticals Incorporated (VRTX) published its most recent earnings results on 04-11-2025.
What is Vertex Pharmaceuticals Incorporated's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)'s trailing twelve months ROE is 19.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vertex Pharmaceuticals Incorporated (VRTX) currently has a ROA of 14.78%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VRTX's net profit margin stand at?
VRTX reported a profit margin of 31.35% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VRTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.36 in the most recent quarter. The quick ratio stood at 2.00, with a Debt/Eq ratio of 0.07.